Effects of delayed immune-response in tumor immune-system interplay

@inproceedings{Caravagna2012EffectsOD,
  title={Effects of delayed immune-response in tumor immune-system interplay},
  author={Giulio Caravagna and Alex Graudenzi and Marco Antoniotti and Giancarlo Mauri and Alberto d’Onofrio},
  booktitle={International Workshop on Hybrid Systems Biology},
  year={2012}
}
Tumors constitute a wide family of diseases kinetically characterized by the co-presence of multiple spatio-temporal scales. So, tumor cells ecologically inte rplay with other kind of cells, e.g. endothelial cells or immune system effectors, producing and exchanging various chemical signals. As such, tumor growth is an ideal object of hybrid modeling where discrete stochastic processes model agents at low concentrations, and mean-field equations mode l chemical signals. In previous works we… 

Figures from this paper

Distributed delays in a hybrid model of tumor-immune system interplay.

This work presents a hybrid model with a generic delay kernel accounting that is a Stochastic Hybrid Automata and its semantics is a Piecewise Deterministic Markov process where a two-dimensional stochastic process is interlinked to a multi-dimensional mean-field system.

Mathematical modelling and analysis of tumor immune system

This thesis introduces adoptive cellular immunotherapy (ACI) as the treatment to boost the immune system to fight against tumors and develops mathematical models to explore the role of HTCs in the tumor immune system (T-IS).

Effects of Lévy noise and immune delay on the extinction behavior in a tumor growth model

The combined effects of Levy noise and immune delay on the extinction behavior in a tumor growth model are explored. The extinction probability of tumor with certain density is measured by exit

Hybrid semantics for Bio-PEPA

References

SHOWING 1-10 OF 58 REFERENCES

Modeling immunotherapy of the tumor – immune interaction

The dynamics between tumor cells, immune-effector cells, and IL-2 are illustrated through mathematical modeling and the effects of adoptive cellular immunotherapy are explored to explain both short tumor oscillations in tumor sizes as well as long-term tumor relapse.

Fine-tuning anti-tumor immunotherapies via stochastic simulations

The model suggests that Interleukin-based therapies may not be effective for every patient, and that the piece-wise constant is the most effective delivery to stimulate the immune-response.

TUMOR-IMMUNE SYSTEM INTERACTION: MODELING THE TUMOR-STIMULATED PROLIFERATION OF EFFECTORS AND IMMUNOTHERAPY

The influence of the proliferation response of effectors to tumor burden, and of cooperation and/or competition between immune system effectors, is studied by means of three inter-related bi-dimensional meta-models, by studying the location and the local stability of the equilibria.

A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth

A new mathematical model that describes tumor-immune interactions, focusing on the role of natural killer and CD8+ T cells in tumor surveillance, is presented, with the goal of understanding the dynamics of immune-mediated tumor rejection.

A validated mathematical model of cell-mediated immune response to tumor growth.

A new mathematical model that describes tumor-immune interactions, focusing on the role of natural killer and CD8+ T cells in tumor surveillance, is presented, with the goal of understanding the dynamics of immune-mediated tumor rejection.

Tumor-induced death of immune cells: its mechanisms and consequences.

When put in the context of biologic interactions that take place at the tumor site, the Fas/FasL pathway emerges as a molecular mechanism, which contributes to immune privilege and tumor escape, but which can also enhance anti-tumor inflammatory responses.

Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.

This research combines hitherto unrelated or even contradictory data within the range of behavior of one model of the macrophage T lymphocyte interactions that generate an anti-tumor immune response.

Does the immune system see tumors as foreign or self?

  • D. Pardoll
  • Biology, Medicine
    Annual review of immunology
  • 2003
To elude immune surveillance, tumors must develop mechanisms that block the elaboration and sensing of proinflammatory danger signals, thereby shifting the balance from activation to tolerance induction.

The three Es of cancer immunoediting.

The history of the cancer immunosurveillance controversy is summarized and its resolution and evolution into the three Es of cancer immunoediting--elimination, equilibrium, and escape are discussed.
...